Ken Griffin Seer, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.59 - $2.07 $795 - $1,035	500 Added 500.0%	600 $1,000
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.24 $165 - $224	100 New	100 $0
Q4 2023 Feb 14, 2024	SELL	$1.47 - $2.22 $6,615 - $9,990	-4,500 Reduced 81.82%	1,000 $1,000
Q3 2023 Nov 14, 2023	BUY	$2.18 - $5.52 $3,270 - $8,280	1,500 Added 37.5%	5,500 $12,000
Q2 2023 Aug 14, 2023	SELL	$3.16 - $4.96 $100,804 - $158,224	-31,900 Reduced 88.86%	4,000 $17,000
Q1 2023 May 15, 2023	BUY	$3.6 - $5.88 $118,800 - $194,040	33,000 Added 1137.93%	35,900 $138,000
Q4 2022 Feb 14, 2023	BUY	$5.03 - $8.58 $14,587 - $24,882	2,900 New	2,900 $16,000

35.2M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $135M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.